DURECT Shares Outstanding 2006-2020 | DRRX

DURECT shares outstanding from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
DURECT Annual Shares Outstanding
(Millions of Shares)
2019 178
2018 160
2017 145
2016 133
2015 119
2014 112
2013 103
2012 89
2011 87
2010 87
2009 83
2008 78
2007 70
2006 66
2005 54
DURECT Quarterly Shares Outstanding
(Millions of Shares)
2020-03-31 196
2019-12-31 178
2019-09-30 192
2019-06-30 164
2019-03-31 162
2018-12-31 160
2018-09-30 162
2018-06-30 162
2018-03-31 154
2017-12-31 145
2017-09-30 152
2017-06-30 143
2017-03-31 142
2016-12-31 133
2016-09-30 138
2016-06-30 133
2016-03-31 122
2015-12-31 119
2015-09-30 120
2015-06-30 119
2015-03-31 114
2014-12-31 112
2014-09-30 112
2014-06-30 111
2014-03-31 110
2013-12-31 103
2013-09-30 102
2013-06-30 102
2013-03-31 102
2012-12-31 89
2012-09-30 88
2012-06-30 88
2012-03-31 88
2011-12-31 87
2011-09-30 87
2011-06-30 87
2011-03-31 87
2010-12-31 87
2010-09-30 87
2010-06-30 87
2010-03-31 87
2009-12-31 83
2009-09-30 83
2009-06-30 82
2009-03-31 82
2008-12-31 78
2008-09-30 82
2008-06-30 75
2008-03-31 74
2007-12-31 70
2007-09-30 70
2007-06-30 69
2007-03-31 69
2006-12-31 66
2006-09-30 69
2006-06-30 64
2006-03-31 62
2005-12-31 54
2005-09-30 53
2005-06-30 52
2005-03-31 52
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.419B $0.030B
Durect Corp. is pioneering the treatment of chronic diseases and conditions by developing and commercializing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time. Its pharmaceutical systems combine engineering innovations and delivery technology from the medical device and drug delivery industries with its proprietary pharmaceutical and biotechnology drug formulations.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $66.682B 37.84
Takeda Pharmaceutical (TAK) Japan $54.637B 9.57
Astellas Pharma (ALPMY) Japan $29.826B 15.11
UCB SA (UCBJF) Belgium $24.547B 0.00
Eisai (ESALY) Japan $23.752B 20.59
Merck (MKGAF) Germany $16.026B 21.02
Grifols, S.A (GRFS) Spain $13.215B 16.43
Catalent (CTLT) United States $12.286B 47.50
Neurocrine Biosciences (NBIX) United States $12.176B 56.28
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.568B 45.56
IPSEN SA ADR (IPSEY) France $7.709B 0.00
Orion OYJ (ORINY) Finland $7.077B 31.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.349B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.939B 9.50
United Therapeutics (UTHR) United States $5.210B 9.87
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.818B 526.00
Nektar Therapeutics (NKTR) United States $4.199B 0.00
Evotec AG (EVTCY) Germany $4.040B 108.88
FibroGen (FGEN) United States $3.748B 0.00
Hypermarcas (HYPMY) Brazil $3.724B 13.70
ChemoCentryx (CCXI) United States $3.625B 0.00
PTC Therapeutics (PTCT) United States $3.566B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.505B 10.29
Pacira BioSciences (PCRX) United States $2.331B 47.70
Sage Therapeutics (SAGE) United States $2.266B 0.00
Cronos Group (CRON) Canada $2.233B 64.00
Corcept Therapeutics (CORT) United States $1.869B 18.53
Xencor (XNCR) United States $1.825B 0.00
USANA Health Sciences (USNA) United States $1.786B 18.32
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.631B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.629B 12.46
Akebia Therapeutics (AKBA) United States $1.551B 0.00
Zogenix (ZGNX) United States $1.516B 0.00
Heron Therapeutics (HRTX) United States $1.487B 0.00
Indivior (INVVY) United States $1.421B 17.64
Karyopharm Therapeutics (KPTI) United States $1.412B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.398B 15.06
Theravance Biopharma (TBPH) Cayman Islands $1.339B 0.00
Esperion Therapeutics (ESPR) United States $1.310B 0.00
VAXART, INC (VXRT) United States $1.259B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.200B 0.00
Translate Bio (TBIO) United States $1.164B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.034B 46.13
Tilray (TLRY) Canada $0.945B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.923B 0.00
Endo (ENDP) Ireland $0.774B 1.20
ImmunoGen (IMGN) United States $0.749B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.695B 0.00
Trillium Therapeutics (TRIL) Canada $0.622B 0.00
Radius Health (RDUS) United States $0.614B 0.00
Aerie Pharmaceuticals (AERI) United States $0.611B 0.00
Collegium Pharmaceutical (COLL) United States $0.572B 0.00
Ardelyx (ARDX) United States $0.568B 0.00
Molecular Templates (MTEM) United States $0.558B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.524B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.513B 12.40
Flexion Therapeutics (FLXN) United States $0.506B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.500B 0.00
Innate Pharma SA (IPHYF) France $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.481B 18.78
Siga Technologies (SIGA) United States $0.477B 0.00
Altimmune (ALT) United States $0.451B 0.00
TherapeuticsMD (TXMD) United States $0.405B 0.00
Ocular Therapeutix (OCUL) United States $0.403B 0.00
Harpoon Therapeutics (HARP) United States $0.376B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.373B 0.00
MEI Pharma (MEIP) United States $0.359B 0.00
Calithera Biosciences (CALA) United States $0.359B 0.00
Organogenesis Holdings (ORGO) United States $0.349B 0.00
Concert Pharmaceuticals (CNCE) United States $0.303B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.287B 0.00
IMV INC (IMV) Canada $0.286B 0.00
PROFOUND MEDICL (PROF) Canada $0.267B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.253B 0.00
Taiwan Liposome (TLC) Taiwan $0.231B 0.00
Redhill Biopharma (RDHL) Israel $0.225B 0.00
OptiNose (OPTN) United States $0.218B 0.00
CASI Pharmaceuticals (CASI) United States $0.212B 0.00
Rafael Holdings (RFL) United States $0.208B 0.00
KalVista Pharmaceuticals (KALV) United States $0.206B 0.00
Lannett Co Inc (LCI) United States $0.198B 4.34
Nature's Sunshine Products (NATR) United States $0.188B 24.77
Jounce Therapeutics (JNCE) United States $0.174B 4.16
Nivalis Therapeutics (ALPN) United States $0.168B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.149B 0.00
Aquestive Therapeutics (AQST) United States $0.139B 0.00
Otonomy (OTIC) United States $0.124B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.117B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.114B 0.00
Xeris Pharmaceuticals (XERS) United States $0.106B 0.00
Champions Oncology (CSBR) United States $0.105B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.103B 0.00
MediWound (MDWD) Israel $0.103B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
Heat Biologics (HTBX) United States $0.100B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.100B 0.00
Recro Pharma (REPH) United States $0.098B 0.00
Onconova Therapeutics (ONTX) United States $0.094B 0.00
CTI BioPharma (CTIC) United States $0.092B 0.00
Sundial Growers (SNDL) Canada $0.090B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.090B 0.00
Biomerica (BMRA) United States $0.086B 0.00
Hemispherx BioPharma (AIM) United States $0.085B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.082B 0.00
ElectroCore (ECOR) United States $0.070B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
Lipocine (LPCN) United States $0.059B 0.00
Addex Therapeutics (ADXN) Switzerland $0.057B 0.00
CV Sciences (CVSI) United States $0.056B 0.00
PolarityTE (PTE) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 28.91
Natural Alternatives (NAII) United States $0.047B 0.00
Infinity Pharmaceuticals (INFI) United States $0.047B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.045B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.045B 0.00
IsoRay (ISR) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Mannatechorporated (MTEX) United States $0.041B 7.70
Novan (NOVN) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 85.18
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Jaguar Animal Health (JAGX) United States $0.037B 0.00
GTx (ONCT) United States $0.036B 0.00
AgeX Therapeutics (AGE) United States $0.034B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.033B 0.00
Neos Therapeutics (NEOS) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.018B 0.00
Iterum Therapeutics (ITRM) Ireland $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Can-Fite Biopharma (CANF) Israel $0.016B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 31.57
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Shineco (TYHT) China $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.008B 0.00
Vical (BBI) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00